Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination formulation** containing **testosterone cypionate**, an androgenic hormone ester, and **isopropyl alcohol**, typically used as a solvent or penetration enhancer. **Testosterone cypionate** acts primarily as a testosterone replacement therapy in adult males with diagnosed testosterone deficiency (hypogonadism). It is administered via intramuscular injection, though isopropyl alcohol can be used to prepare topical or injectable testosterone solutions and may enhance drug solubility or skin permeation[9][15]. Testosterone cypionate binds to androgen receptors, promoting male secondary sexual characteristics, muscle growth, and protein synthesis. Isopropyl alcohol in the combination serves no direct pharmacological role but improves drug delivery or formulation stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + testosterone cypionate.